These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7212769)

  • 1. In vitro studies on the human cellular immune response to commercially available herpes simplex antigens.
    Czarnetzki BM; Macher E
    Arch Dermatol Res; 1980; 268(3):247-55. PubMed ID: 7212769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell-mediated immune responses in patients with recurrent Herpes Simplex infections. II. Infection-associated deficiency of lymphokine production in patients with recurrent herpes labialis or herpes progenitalis.
    O'Reilly RJ; Chibbaro A; Anger E; Lopez C
    J Immunol; 1977 Mar; 118(3):1095-1102. PubMed ID: 191524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell mediated immunity to herpes simplex in man. IV. A correlation of lymphocyte stimulation and inhibition of leukocyte migration.
    Russell AS; Kaiser J; Lao VS
    J Immunol Methods; 1976; 9(3-4):273-9. PubMed ID: 175120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunotherapy of recurrent Herpes simplex diseases].
    Wassilew SW
    Hautarzt; 1979 Jun; 30(6):287-91. PubMed ID: 378899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular immunity and circulating antibody to herpes simplex virus in subjects with recurrent herpex simplex lesions and controls as measured by the mixed leukocyte migration inhibition test and complement fixation.
    Gange RW; de Bats A; Park JR; Bradstreet CM; Rhodes EL
    Br J Dermatol; 1975 Nov; 93(5):539-44. PubMed ID: 173386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular immune responses to Herpes simplex virus type 1 in recurrent herpes labialis: in vitro blastogenesis and cytotoxicity to infected cell line.
    Steele RW; Vincent MM; Hensen SA; Fuccillo DA; Chapa IA; Canales L
    J Infect Dis; 1975 May; 131(5):528-34. PubMed ID: 165245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphocyte transformation and interferon production in human mononuclear cell microcultures for assay of cellular immunity to herpes simplex virus.
    Haahr S; Rasmussen L; Merigan TC
    Infect Immun; 1976 Jul; 14(1):47-54. PubMed ID: 181328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Humoral and cellular immune responses to an envelope-associated antigen of herpes simplex virus.
    Zaia JA; Palmer EL; Feorino PM
    J Infect Dis; 1975 Dec; 132(6):660-6. PubMed ID: 172562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of T lymphocytes in cellular immune responses during herpes simplex virus infection in humans.
    Rasmussen L; Merigan TC
    Proc Natl Acad Sci U S A; 1978 Aug; 75(8):3957-61. PubMed ID: 308659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [General immune reactivity and herpes genitalis (author's transl)].
    Ishiguro T; Yoshida Y; Tenzaki T
    Acta Obstet Gynaecol Jpn; 1981 May; 33(5):659-63. PubMed ID: 7234353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA antigens in patients with recrudescent herpes simplex infections.
    Legendre C; Russell AS; Jeannet M
    Tissue Antigens; 1982 Jan; 19(1):85-9. PubMed ID: 6280337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The lymphocyte transformation test in patients with recurrent herpes simplex diseases (author's transl)].
    Wassilew SW; Koch I
    Arch Dermatol Res; 1978 Aug; 262(3):267-74. PubMed ID: 214045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-mediated immunity to herpes simplex virus types 1 and 2 antigens in leukoplakia and carcinoma in man.
    Shillitoe EJ; Tarro G; Lehner T
    Oncology; 1976; 33(4):192-5. PubMed ID: 65753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delta-9-tetrahydrocannabinol inhibits the splenocyte proliferative response to herpes simplex virus type 2.
    Cabral GA; McNerney PJ; Mishkin EM
    Immunopharmacol Immunotoxicol; 1987; 9(2-3):361-70. PubMed ID: 2830329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapy of recurrent herpes simplex and its surveillance by MIF determination: with levamisole, BCG, urushiol and herpes antigen vaccine (author's transl)].
    Jarisch R; Sandor I
    Arch Dermatol Res (1975); 1977 Apr; 258(2):151-9. PubMed ID: 141241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylactic Herpes Simplex Virus 2 (HSV-2) Vaccines Adjuvanted with Stable Emulsion and Toll-Like Receptor 9 Agonist Induce a Robust HSV-2-Specific Cell-Mediated Immune Response, Protect against Symptomatic Disease, and Reduce the Latent Viral Reservoir.
    Hensel MT; Marshall JD; Dorwart MR; Heeke DS; Rao E; Tummala P; Yu L; Cohen GH; Eisenberg RJ; Sloan DD
    J Virol; 2017 May; 91(9):. PubMed ID: 28228587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-mediated immunity against herpes simplex virus envelope, capsid, excreted, and crude antigens.
    Kalimo KO; Joronen IA; Havu VK
    Infect Immun; 1983 Jan; 39(1):24-8. PubMed ID: 6295957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphocyte proliferation and IgG production with herpesvirus antigens in solid phase.
    Ljungman P; Wahren B; Sundqvist VA
    J Virol Methods; 1985 Dec; 12(3-4):199-208. PubMed ID: 2422193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Herpes simplex virus (HSV) with cervical cancer by lymphocyte reactivity with HSV-1 and HSV-2 antigens.
    Smith JW; Torres JE; Holmquist ND
    Am J Epidemiol; 1979 Aug; 110(2):141-7. PubMed ID: 223438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T cell immunity to herpes simplex viruses in seronegative subjects: silent infection or acquired immunity?
    Posavad CM; Wald A; Hosken N; Huang ML; Koelle DM; Ashley RL; Corey L
    J Immunol; 2003 Apr; 170(8):4380-8. PubMed ID: 12682275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.